Medicare Enrolled
Dr. Ryan Zuzek, M.D.
Interventional Cardiology · Pittsburgh, PA
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zuzek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zuzek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zuzek
Dr. Ryan Zuzek is an interventional cardiology specialist in Pittsburgh, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zuzek performed 2,425 Medicare services across 1,723 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zuzek received a total of $198,077 from 50 pharmaceutical and/or device companies across 905 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zuzek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 14% volume in PA
$198,077 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,425
Medicare services
Top 14% in PA for interventional cardiology
1,723
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~128 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
467 | $9 | $72 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
407 | $81 | $314 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
217 | $14 | $73 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
188 | $89 | $309 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
168 | $19 | $90 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
132 | $49 | $208 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
121 | $6 | $26 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
86 | $25 | $106 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
83 | $123 | $602 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
82 | $10 | $43 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
75 | $57 | $236 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
70 | $18 | $79 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
59 | $16 | $65 |
| New patient office visit, complex (60-74 min) | 49 | $146 | $607 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
46 | $25 | $112 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
30 | $9 | $43 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
26 | $17 | $74 |
| Cardiac catheterization | 25 | $153 | $1,251 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
22 | $44 | $230 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
17 | $417 | $1,747 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $112 | $425 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $281 | $1,665 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
12 | $75 | $321 |
| Transcatheter aortic valve replacement via femoral artery A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery. |
11 | $570 | $3,590 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.3% high complexity
9.4% medium
64.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$198,077
Total received (2018-2024)
Avg $28,297/year across 7 years
Top 5% in PA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
905
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$154,312 (77.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$28,651 (14.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,114 (7.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,536
2023
$10,033
2022
$15,286
2021
$16,470
2020
$35,190
2019
$44,492
2018
$62,070
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$8,169
Janssen Pharmaceuticals, Inc
$3,917
ABIOMED
$459
Abbott Laboratories
$423
Medtronic, Inc.
$402
Boston Scientific Corporation
$361
Lexicon Pharmaceuticals, Inc.
$208
Terumo Medical Corporation
$156
CVRx, Inc.
$72
Novartis Pharmaceuticals Corporation
$71
Teleflex LLC
$61
Novo Nordisk Inc
$54
iRhythm Technologies, Inc.
$44
ShockWave Medical, Inc
$32
W. L. Gore & Associates, Inc.
$25
SCPHARMACEUTICALS INC.
$19
PFIZER INC.
$18
E.R. Squibb & Sons, L.L.C.
$16
AstraZeneca Pharmaceuticals LP
$15
AltaThera Pharmaceuticals LLC
$9
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$6
Top 3 companies account for 86.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$58,043
Esperion Therapeutics, Inc.
$25,358
Novartis Pharmaceuticals Corporation
$23,947
Edwards Lifesciences Corporation
$22,687
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$15,261
Regeneron Healthcare Solutions, Inc.
$14,820
PFIZER INC.
$9,430
SANOFI-AVENTIS U.S. LLC
$6,928
Janssen Pharmaceuticals, Inc
$5,128
E.R. Squibb & Sons, L.L.C.
$3,898
BIOTRONIK INC.
$3,084
Abbott Laboratories
$1,280
Boston Scientific Corporation
$1,194
ABIOMED
$817
Medtronic, Inc.
$727
Siemens Medical Solutions USA, Inc.
$697
AstraZeneca Pharmaceuticals LP
$629
Cook Medical LLC
$570
BOSTON SCIENTIFIC CORPORATION
$507
Actelion Pharmaceuticals US, Inc.
$366
Gilead Sciences, Inc.
$298
CVRx, Inc.
$276
Lexicon Pharmaceuticals, Inc.
$250
Kestra Medical Technology Services, Inc.
$210
Teleflex LLC
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$172
Terumo Medical Corporation
$156
Amarin Pharma Inc.
$124
Astellas Pharma US Inc
$102
United Therapeutics Corporation
$100
AtriCure, Inc.
$99
Akcea Therapeutics, Inc.
$98
CARDIVA MEDICAL, INC.
$62
W. L. Gore & Associates, Inc.
$62
GENZYME CORPORATION
$60
Bayer HealthCare Pharmaceuticals Inc.
$54
Novo Nordisk Inc
$54
PORTOLA PHARMACEUTICALS, INC.
$51
Allergan Inc.
$49
iRhythm Technologies, Inc.
$44
ShockWave Medical, Inc
$32
Medtronic Vascular, Inc.
$28
Kowa Pharmaceuticals America, Inc.
$25
Amryt Pharma Holdings Ltd
$22
Corindus Inc.
$19
SCPHARMACEUTICALS INC.
$19
Tactile Systems Technology Inc
$13
Lundbeck LLC
$11
AltaThera Pharmaceuticals LLC
$9
ZOLL Circulation Inc
$7
Top 3 companies account for 54.2% of all-time payments
Associated products mentioned in payments ›
ACC2 CARDIAC CRYOSURGICAL SYSTEM · ACCOLADE · ACCOLADE SR · ACUITY Steerable · ANDEXXA · AUBAGIO · AVVIGO Guidance System · Acticor · Adempas · AngioJet Ultra 5000A · Assure WCD · BEVYXXA · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor · BioMonitor 2 · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CHANTIX · COMET · CONFIRM RX · COOK MEDICAL ACCESSORIES · COOK MEDICAL ZILVER PTX · COREVALVE EVOLUT R · CardioMEMS HF System · Comet · Confirm Rx · Connectivity and Remote care · Cook Medical AAA · Cook Medical Accessories · Cook Medical Angioplasty · Cook Medical Catheters · Cook Medical Filters · Cook Medical Self-Expanding Stent · Cook Medical Zilver PTX · CorPath GRX · CorPath Imaging System · CoreValve Evolut · Corlanor · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · ENDOTAK RELIANCE S · ENSITE · ENTRESTO · ESSENTIO · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FINELINE · FINELINE II Sterox · FLEXITOUCH · FUROSCIX · GENERAL THERAPIES · GENERAL THERAPIES · GENERAL - THERAPIES · GLIDESHEATH SLENDER · GORE CARDIOFORM Septal Occluder · GUIDELINER · GUIDEZILLA · INGEVITY · Impella · Inpefa · JARDIANCE · JOT DX · JUXTAPID · LANGSTON · LATITUDE · LEQVIO · LEXISCAN · LOKELMA · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MANTA · MARVEL · MITRACLIP · MULTAQ · MYLUX · NAVITOR · NEXLETOL · NEXLIZET · NORTHERA · OPSUMIT · OPSUMIT MACITENTAN · OPTICROSS · ORENITRAM · OptiCross · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QTRAK ELECTRODE · RESONATE · RESONATE EL ICD VR · ROTABLATOR · Repatha · Reveal LINQ · S-ICD System Magnet · SAPIEN 3 Ultra RESILIA · SENSOR ENABLED · SUPERCROSS · SYNERGY · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave M5+ · Shockwave Medical L6 Intravascular Lithotripsy (IVL) Catheter · Sotalol Hydrochloride · TACTICATH ABLATION CATHETER · TEGSEDI · TRAPLINER · TURNPIKE · TYVASO · Temperature Management System · Torcon NB · UPTRAVI · VRAYLAR · VYNDAQEL · Vascepa · Verquvo · WATCHMAN · WATCHMAN Access System · WOLVERINE · Wegovy · XARELTO · ZIO XT Patch · ZOOM · Zilver PTX · Zio monitor · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for interventional cardiology in PA.
Geographic Context
Interventional cardiologists within 10 mi
26
Per 100K population
2.1
County median income
$76,393
Nearest hospital
ST CLAIR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zuzek is an electrophysiology & remote specialist, with above-average Medicare volume (top 14% in PA), with speaking/promotional industry engagement in the top 5% of PA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zuzek experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Zuzek performed 467 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zuzek receive payments from pharmaceutical companies?
Yes. Dr. Zuzek received a total of $198,077 from 50 companies across 905 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zuzek's costs compare to other interventional cardiologists in Pittsburgh?
Dr. Zuzek's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zuzek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Pittsburgh
Browse interventional cardiologists in Pittsburgh ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in PA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in PA
Which PA interventional cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Esperion Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Esperion Therapeutics, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology